Work

Abstract A11: Lower baseline levels of plasma hepatocyte growth factor, IL-6, and IL-8 are correlated with greater tumor shrinkage in renal cell carcinoma patients treated with pazopanib

Year: 2009

Type: conference-abstract

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.targ-09-a11

Authors: John V. Heymach, Hai T. Tran, Herbert A. Fritsche, Terrie G. Gornet, Yuan Liu, Dilip Rajagopalan, Anne-Marie Martin, Katherine L. Baker, Louise Downie, Thomas E. Hutson, Robert A. Figlin, VEG102616 Team, Rafael G. Amado, Lini N. Pandite

Institutions: The University of Texas MD Anderson Cancer Center, GlaxoSmithKline (United States), City Of Hope National Medical Center

Language: English

Topic: Renal cell carcinoma treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2006667057

Cites:

Cited by: 9

Related to: 10